Titre :
  • Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
Auteur : Vermorken, Jan Baptist ; Remenar, Eva ; van Herpen, C M L ; Gorlia, Thierry ; Mesia, Ricard ; Degardin, Marian ; Stewart, J ; Jelic, Svetislav ; Betka, Jan ; Preiss, Joachim H ; Van Den Weyngaert, Danielle ; Awada, Ahmad ; Cupissol, Didier ; Kienzer, Heinz R ; Rey, Augustin ; Desaunois, Isabelle ; Bernier, J ; Lefebvre, Jean-Louis ; EORTC 24971/TAX 323 Study Group
Informations sur la publication : The New England journal of medicine, 357, 17, (page 1695-1704)
Statut de publication : Publié, 2007-10
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Carcinoma, Squamous Cell -- drug therapy
Carcinoma, Squamous Cell -- radiotherapy
Carcinoma, Squamous Cell -- surgery
Cisplatin -- administration & dosage
Combined Modality Therapy
Disease-Free Survival
Female
Fluorouracil -- administration & dosage
Head and Neck Neoplasms -- drug therapy
Head and Neck Neoplasms -- radiotherapy
Head and Neck Neoplasms -- surgery
Humans
Male
Middle Aged
Neoplasm Staging
Radiotherapy -- adverse effects
Survival Analysis
Taxoids -- administration & dosage
Note : Clinical Trial, Phase III
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0028-4793 
info:doi/10.1056/NEJMoa071028
info:pii/357/17/1695
info:pmid/17960012